Estonsko - estonština - Ravimiamet

laboratorio farmaceutico sit srl - griseofulviin - tablett - 125mg 20tk

Estonsko - estonština - Ravimiamet

biosintez oao - etamsülaat - süstelahus - 125mg 1ml 2ml 10tk

Evropská unie - estonština - EMA (European Medicines Agency)

novartis europharm limited  - indacaterol, mometasone furoate - astma - ravimid hingamisteede obstruktiivsete haiguste, - bemrist breezhaler is indicated as a maintenance   treatment of asthma in adults and adolescents 12 years of age and older not adequately controlled with inhaled corticosteroids and inhaled short acting beta2-agonists.

Evropská unie - estonština - EMA (European Medicines Agency)

novartis europharm limited  - indacaterol acetate, mometasone furoate - astma - ravimid hingamisteede obstruktiivsete haiguste, - atectura breezhaler is indicated as a maintenance treatment of asthma in adults and adolescents 12 years of age and older not adequately controlled with inhaled corticosteroids and inhaled short acting beta2-agonists.

Estonsko - estonština - Ravimiamet

strides pharma uk limited - vankomütsiin - kõvakapsel - 125mg 30tk

Estonsko - estonština - Ravimiamet

mw encap limited - vankomütsiin - kõvakapsel - 125mg 28tk

Estonsko - estonština - Ravimiamet

abbvie s.r.l. - klaritromütsiin - suukaudse suspensiooni graanulid - 125mg 5ml 120ml 1tk

Estonsko - estonština - Ravimiamet

fairmed healthcare gmbh - vankomütsiin - kõvakapsel - 125mg 30tk

Evropská unie - estonština - EMA (European Medicines Agency)

mylan pharmaceuticals limited - darunaviiri - hiv-nakkused - viirusevastased ravimid süsteemseks kasutamiseks - darunavir, co-administered with low dose ritonavir is indicated in combination with other antiretroviral medicinal products for the treatment of patients with human immunodeficiency virus (hiv-1) infection (see section 4. darunavir mylan 75 mg, 150 mg, 300 mg and 600 mg tablets may be used to provide suitable dose regimens (see section 4. 2):ravi hiv-1 nakkuse retroviirusevastast ravi (art)-kogenud täiskasvanud patsientidele, sealhulgas neid, mis on väga eeltöödeldud. ravi hiv-1 nakkuse pediaatrilised patsiendid alates vanusest 3 aastat ja vähemalt 15 kg kehakaalu kohta. otsustades ravi alustada darunavir co-manustatakse koos väikeses annuses ritonaviiri, tuleks hoolikalt kaaluda ravi ajalugu konkreetse patsiendi ja mustreid mutatsioonid on seotud erinevate mõjurite. genotypic or phenotypic testing (when available) and treatment history should guide the use of darunavir (see sections 4. 2, 4. 4 ja 5. darunavir co-manustatakse koos väikeses annuses ritonaviir on näidustatud kombinatsioonis teiste viirusevastase ravimitega ravi patsientidel, kellel on inimese immuunpuudulikkuse viiruse (hiv-1) nakkus.  darunavir co-administered with cobicistat is indicated in combination with other antiretroviral medicinal products for the treatment of human immunodeficiency virus (hiv-1) infection in adults and adolescents (aged 12 years and older, weighing at least 40 kg) (see section 4.  darunavir mylan 400 mg and 800 mg tablets may be used to provide suitable dose regimens for the treatment of hiv-1 infection in adult and paediatric patients from the age of 3 years and at least 40 kg body weight who are: antiretroviral therapy (art)-naïve (see section 4.  art-experienced with no darunavir resistance associated mutations (drv-rams) and who have plasma hiv-1 rna < 100,000 copies/ml and cd4+ cell count ≥ 100 cells x 10⁶/l. otsustades ravi alustada darunavir sellisel kunsti-kogenud patsientidel, genotypic katsetamine peaks juhendi kasutamine darunavir (vt lõigud 4. 2, 4. 3, 4. 4 ja 5.

Estonsko - estonština - Ravimiamet

teva pharma b.v. - levodopa+karbidopa+entakapoon - õhukese polümeerikattega tablett - 175mg+43,75mg+200mg 100tk; 175mg+43,75mg+200mg 50tk; 175mg+43,75mg+200mg 250tk; 175mg+43,75mg+200mg 200tk; 175mg+43,75mg+200mg 130tk; 175mg+43,75mg+200mg 28tk; 175mg+43,75mg+200mg 175tk; 175mg+43,75mg+200mg 90tk; 175mg+43,75mg+200mg 10tk; 175mg+43,75mg+200mg 30tk; 175mg+43,75mg+200mg 60tk; 175mg+43,75mg+200mg 98tk